yucca Reviews
Save up to $400 on your first order
Last updated: Sep 2, 2026
We may earn a commission from links on this page - it never affects our rankings (how we stay objective).
The bottom line
Yucca delivers a clean, modern telehealth experience for patients seeking affordable GLP-1 weight loss treatment. While it lacks the coaching depth of some competitors, its streamlined process, transparent pricing, and licensed clinical oversight make it a compelling option for people who want effective treatment without complexity.
Yucca is a modern telehealth platform focused on making GLP-1 weight loss treatment simple and accessible. Their streamlined process connects patients with licensed clinicians who evaluate eligibility, prescribe medication, and provide ongoing support - all through a clean, easy-to-use online experience.
Key Features
- Fast online eligibility evaluation
- Licensed clinician consultations included
- GLP-1 medication prescribed and delivered
- Affordable, transparent monthly pricing
- Ongoing clinical support and check-ins
Treatment Options
- Compounded semaglutide
- Compounded tirzepatide
- Clinician-guided dosage adjustments
- Ongoing treatment monitoring
Pricing
Yucca offers straightforward monthly plans that include clinician consultations, GLP-1 medication, and home delivery. Pricing is transparent with no hidden fees or long-term contracts.
Pros
- Simple and fast onboarding process
- Affordable pricing compared to competitors
- Licensed clinicians oversee all care
- Clean, modern user experience
- No long-term contracts required
Cons
- Newer platform with limited brand recognition
- Fewer lifestyle support features
- Limited availability in some states
Who It's Best For
- People looking for affordable GLP-1 access
- Those who prefer a fast, simple onboarding process
- Anyone who values a modern, no-frills telehealth experience
Final Verdict
Yucca delivers a clean, modern telehealth experience for patients seeking affordable GLP-1 weight loss treatment. While it lacks the coaching depth of some competitors, its streamlined process, transparent pricing, and licensed clinical oversight make it a compelling option for people who want effective treatment without complexity.
yucca Review: FAQs
Is yucca legit?
Yucca is a modern telehealth platform focused on making GLP-1 weight loss treatment simple and accessible. Their streamlined process connects patients with licensed clinicians who evaluate eligibility, prescribe medication, and provide ongoing support - all through a clean, easy-to-use online experience.
How much does yucca cost?
Yucca offers straightforward monthly plans that include clinician consultations, GLP-1 medication, and home delivery. Pricing is transparent with no hidden fees or long-term contracts.
What treatments does yucca offer?
yucca offers Compounded semaglutide, Compounded tirzepatide, Clinician-guided dosage adjustments, Ongoing treatment monitoring.
Who is yucca best for?
yucca is best for People looking for affordable GLP-1 access; Those who prefer a fast, simple onboarding process; Anyone who values a modern, no-frills telehealth experience.
Is yucca worth it?
Yucca delivers a clean, modern telehealth experience for patients seeking affordable GLP-1 weight loss treatment. While it lacks the coaching depth of some competitors, its streamlined process, transparent pricing, and licensed clinical oversight make it a compelling option for people who want effective treatment without complexity.
Not sure if yucca is right for you?
Take our free quiz and get a personalized provider recommendation.
Find Your MatchRelated
Sources & methodology
We built this review of yucca from the provider'sown published pricing, plans and policies, cross-checked against regulatory and peer-reviewed medical references, and read alongside real customer feedback. Prices and plan details were verified against the provider's published information; we do not take providers' word for their own claims without checking.
Provider information
Pricing, plans, shipping and policies, checked against each provider's own site.
- yucca - pricing, plans & policies as published on its own site
Provider data checked September 2026
Customer & community feedback
Third-party signals shown on this page and in our full reviews: verified Trustpilot ratings, public Reddit discussions, and independent YouTube reviews. We report what these sources say - we never fold their ratings into our own scores.
Medical & regulatory references
- 1.Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1 trial) - New England Journal of Medicine, 2021
- 2.Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1 trial) - New England Journal of Medicine, 2022
- 3.FDA Approves New Drug Treatment for Chronic Weight Management (semaglutide / Wegovy) - U.S. Food & Drug Administration, 2021
- 4.FDA Approves New Medication for Chronic Weight Management (tirzepatide / Zepbound) - U.S. Food & Drug Administration, 2023
- 5.FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss - U.S. Food & Drug Administration
- 6.Human Drug Compounding (503A pharmacy standards) - U.S. Food & Drug Administration
- 7.Semaglutide Injection - drug information - MedlinePlus, U.S. National Library of Medicine (NIH)
Last reviewed September 2026. We revisit comparisons when providers change their pricing or policies. This page is information only and is not medical advice - always consult a licensed clinician before starting treatment.
Sources & medical references
Treatment facts on this page are grounded in regulatory guidance and peer-reviewed research. Pricing and plan details come from each provider's published information. This content is for information only and is not medical advice - always consult a licensed clinician before starting treatment.
- 1.Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1 trial) - New England Journal of Medicine, 2021
- 2.Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1 trial) - New England Journal of Medicine, 2022
- 3.FDA Approves New Drug Treatment for Chronic Weight Management (semaglutide / Wegovy) - U.S. Food & Drug Administration, 2021
- 4.FDA Approves New Medication for Chronic Weight Management (tirzepatide / Zepbound) - U.S. Food & Drug Administration, 2023
- 5.FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss - U.S. Food & Drug Administration
- 6.Human Drug Compounding (503A pharmacy standards) - U.S. Food & Drug Administration
- 7.Semaglutide Injection - drug information - MedlinePlus, U.S. National Library of Medicine (NIH)